UNIVERSAL-BEAUTY
9.12.2021 19:17:05 CET | Business Wire | Press release
The French natural cosmetics company, known for its Végétalement Provence brand, announces a €6m capital raise from a group of investors led by Connect Pro, an investment fund based in Marseille.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209005914/en/
New shareholders
The arrival of new investors to develop Végétalement Provence, is led by Connect Pro alongside the private equity funds BNP Paribas Développement and Etoile Capital, whose membership of leading banking groups, will ensure the sustainability of the support. The financing is completed by the Région Sud Investissement fund.
« We were won over by the commitment and geographic proximity of Connect Pro and its co-investors, to help companies of our region to grow in France and internationally».
Vincent Faraco,
Co-Founder of Universal Beauty Group
Following the transaction, the founders, Vincent Faraco and Jean-Marc Delabre, will remain reference shareholders and will continue to lead the group.
« We are proud to invest in Universal Beauty Group, which will be the first investment of our new Sud Rebound fund launched in June this year. This venture in the heart of the local economic ecosystem is fully in line with our strategy to support the development of key business in our region».
Franck Paoli,
President and Founder of Connect Pro
Partners in growth
The investors’ entry into the company’s capital will allow the business to accelerate its development in the rapidly expanding natural beauty sector, a market expected to show annual growth of 6-9% over the period 2021-2027.
This transaction follows the first investment in the company’s capital in 2017 made by the private-equity fund Audacia, whose support has made it possible to double the number of product references and open 3 own-brand concept salons alongside about twenty independent concept salons under the Végétalement Provence brand, including the most recent salon opened in Lyon in October.
Végétalement Provence – a committed beauty brand
In 2008, Universal Beauty Group started as a distributor of haircare brands before launching its own brand Végétalement Provence in 2011 to offer hairdressing professionals a technical product that was kinder to the environment and customers’ health. In the space of a few years, Végétalement Provence has become a premium beauty brand recognized as much by professionals as by a general public in search of wellness.
With 170,000 products sold in 2020, Universal Beauty Group forecasts sales of €4m in 2021, with an EBITDA margin of around 20%. 70% of sales are made in mainland France, 15% in the French island of Reunion, and 15% internationally. Its eco-responsible products have been rewarded with numerous prizes for their innovation, and are acclaimed by international colourists and hair stylists in search of natural and high-performance products. The brand is distributed via more than 500 points of sale and through its own e-shop.
Established in Saint-Rémy-de-Provence in the South of France since 2014, Universal Beauty Group, with the support of its teams, training academy, and logistics base, is ready to become a major player in alternative cosmetics and beauty.
« We are delighted to welcome our new partners who will bring their vision and support to the growth of Végétalement Provence whose potential is limitless ».
Jean-Marc Delabre,
Co-Founder of Universal Beauty Group
Among the projects for Végétalement Provence
The product range, designed and developed in Saint-Rémy-de-Provence will be further expanded. With the support of its new investor base focused on the region, Universal Beauty will place a particular emphasis on innovation
The company also plans to open a concept store in Paris in Spring 2022, a new base for Végétalement Provence. A significant investment will be dedicated to the digital development of the brand and to support e-commerce. Previously centred more on its domestic market, the new round of financing will allow the company to consolidate its international expansion.
"We are delighted to accompany the leaders of Végétalement Provence in this great adventure. With its unique products, Végétalement Provence responds to a fundamental trend. The increase in the number of people looking for natural products continues to grow and will offer significant development opportunities."
Rémy Garello,
Managing Director of Connect Pro
Fundraising process
The transaction is the conclusion of a competitive process launched in May 2021 to search for an investor. The process attracted very strong interest both in France and abroad from haircare and beauty companies, as well as private equity and family offices.
Universal Beauty Group was advised by Richard Morgan Advisory (Richard Morgan) and the law firm Volt Associés (Stéphane Letranchant, Lucas d'Orgeval). The investors were advised by the law firm Nova Partners (Olivier Nett, Julien Immoff), with the financial audit carried out by Deloitte Finance (Thomas Gorguis).
Universal Beauty Group - Végétalement Provence
Since its launch in 2011, with its hair and skincare ranges, Végétalement Provence quickly established itself as a real alternative to major brands among hairdressers and beauty professionals.
Its efficient plant-based product ranges, with natural and organic sourcing, meet the needs of a demanding professional public looking for technical prowess with a philosophy of eco-responsibility. In addition to the attractiveness and performance of its products, Universal Beauty Group benefits from a network of professional customers whose resale rate of Végétalement Provence products is unparalleled. While the usual resale rate of the sector in France is around 5%, it exceeds 20% with Végétalement Provence.
Today the brand offers a range of over 275 different beauty product references including 140 in hair and skincare for the general public, covering all needs.
Its ranges combine not just beauty and health, but also wellness based on the foundation of innovation and commitment.
The development of creative styling products, and the introduction of a specific line for ethnic hair, complete the product range. The Essentiels collection, with its shampoos and conditioners, has become a must-have for lovers of the brand.
For its professional clientele, Végétalement Provence offers a range of more than 130 colouring references, with an offer by oxidation and an organic offer based on plant powder.
Végétalement Provence currently has about twenty employees in its Saint-Rémy-de-Provence headquarters.
Connect Pro
Since its creation in 2007, Connect Pro has been supporting small and midcap businesses in the South of France in their development and transmission needs with more than €70m in capital invested. Among the latest equity investments, Mariton designs, manufacturer and distributer of custom-made mosquito nets and interior blinds, EITP, a heating and air-conditioning company and Pharma Santé Développement, a group of independent pharmacies. With Sud Rebond, Connect Pro launched its third fund in June 2021 with a fundraising of more than €15m from institutional investors and entrepreneurs in the South-East of France. It will be completed by a second round of fundraising in the first half of 2022 to reach €25m.
BNP Paribas Développement
One of the private equity funds of the BNP Paribas banking group, BNP Paribas Développement, manages €1 billion of its own funds, investing directly to support the development of successful mid-sized companies. BNP Paribas Développement, whose mission is to support management teams in the realization of medium-term strategic projects, has a portfolio of more than 400 holdings.
www.bnpparibasdeveloppement.com
Etoile Capital
Etoile Capital, a subsidiary of the bank Crédit du Nord, is a shareholder of French small business in widely diversified sectors, with a portfolio currently of about twenty investments. It positions itself as a shareholder in the capital of corporate clients of the various regional banks that make up the Crédit du Nord group. The fund brings to the shareholders and managers of its invested companies its expertise in strategic thinking and the means to accelerate development.
www.corporatefinance.groupe-credit-du-nord.fr
Région Sud Investissement
Région Sud Investissement is the regional investment company created in 2010 by the Southern Region of France to support the emergence and development of high growth companies.
Région Sud Investissement, endowed with €134m, benefits from the support of the European Union through the ERDF (European Regional Development Fund), which contributes 42% of its funding. Région Sud Investissement is advised by Turenne Groupe in the management of its holdings.
www.regionsudinvestissement.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20211209005914/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom